New Era of ASCVD Lipid Risk Management
Hypertriglyceridemia affects nearly 20% of adults with diabetes despite statin use
ACC AHA guideline on the primary prevention of hypercholestrolemia - wikidoc
ASCVD Risk Estimator
Machine learning models to predict atherosclerotic cardiovascular disease risk in multiethnic, real-world populations | Nature Portfolio Health Community
The cardiovascular disease continuum. ASCVD, atherosclerotic... | Download Scientific Diagram
The Role of GLP-1 RAs in the Management of Type 2 Diabetes and Cardiovascular Risk: Putting it All Together - Part 3 (Monograph)
Diabetes Typ-2 personalisiert behandeln! Paradigmenwechsel in der gemeinsamen Therapie-Leitlinie 2018 der Amerikanischen (ADA) und Europäischen (EASD) Diabetesgesellschaft | DGE Blog
Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol | Cardiovascular Diabetology | Full Text
Aspirin and Statins for Primary CVD Prevention in Men
Frontiers | Clinical Approach to Assessment and Amelioration of Atherosclerotic Vascular Disease in Diabetes
Clinical implications of the log linear association between LDL-C lowering and cardiovascular risk reduction: Greatest benefits when LDL-C >100 mg/dl | PLOS ONE
Guidelines for the Management of High Blood Cholesterol
JCI - Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk
Neue Diabetemedikamente Typ-2-Diabetes - diabetes-news : diabetes-news
Evidence-Based Treatment of Dyslipidemia: Patient-Centered Evaluation and Management
Prevention of Cardiovascular Disease: Highlights for the Clinician of the 2013 American College of Cardiology/American Heart Association Guidelines - Wenger - 2014 - Clinical Cardiology - Wiley Online Library
American College of Cardiology - A new ACC Expert Consensus Decision Pathway aims to fill the gap in clinical care for the management of high-risk atherosclerotic cardiovascular disease (ASCVD) patients with persistent
Risk of Incident Atherosclerotic Cardiovascular DiseaseEvents by Achieved Atherogenic Lipid Levels Among62,428 Statin-Treated Individuals With Diabetes Mellitus - ScienceDirect
Aspirin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease: Summarizing Current Evidence
New Era of ASCVD Lipid Risk Management
Prevention of Cardiovascular Disease: Highlights for the Clinician of the 2013 American College of Cardiology/American Heart Association Guidelines - Wenger - 2014 - Clinical Cardiology - Wiley Online Library
JCM | Free Full-Text | The Impact of Novel Anti-Diabetic Medications on CV Outcomes: A New Therapeutic Horizon for Diabetic and Non-Diabetic Cardiac Patients
![PDF] 8. Cardiovascular Disease and Risk Management | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/90e0d9c8a6a436c53e9920c4bd55e75b95b1288e/5-Table8.1-1.png "PDF] 8. Cardiovascular Disease and Risk Management | Semantic Scholar")
PDF] 8. Cardiovascular Disease and Risk Management | Semantic Scholar
